Janux Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Janux Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Janux Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Janux Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.6M | 66k | 24.44 |
| 2025-06-30 | $2.6M | 111k | 23.10 |
| 2025-03-31 | $5.0M | 186k | 27.00 |
| 2024-12-31 | $8.9M | 166k | 53.54 |
| 2024-09-30 | $1.2M | 26k | 45.43 |
| 2024-06-30 | $1.3M | 30k | 41.89 |
| 2024-03-31 | $327k | 8.7k | 37.65 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas